Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecular Endocrinology

• Publication date

  2006-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ME.2006-0063PMID 16728529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF‐β1–induced apoptosis in rat hepatocytes

  2005cited by this paper
• The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.

  2005cited by this paper
• Similar Patterns of Mitochondrial Vulnerability and Rescue Induced by Genetic Modification of α-Synuclein, Parkin, and DJ-1 in Caenorhabditis elegans*

  2005cited by this paper
• Macrophage Inflammatory Protein 2 Inhibits β-Amyloid Peptide (1-42)-Mediated Hippocampal Neuronal Apoptosis through Activation of Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Signaling Pathways

  2005cited by this paper
• β-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w

  2005cited by this paper
• Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways.

  2005cited by this paper
• Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.

  2004cited by this paper
• Inhibition of the E2F‐1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid β‐peptide‐induced apoptosis of PC12 Cells

  2004cited by this paper
• Gene analysis of the glucocorticoid receptor alpha in Alzheimer's disease.

  2004cited by this paper
• Mineralocorticoid receptor expression and increased survival following neuronal injury

  2003cited by this paper
• Ursodeoxycholic Acid Modulates E2F-1 and p53 Expression through a Caspase-independent Mechanism in Transforming Growth Factor β1-induced Apoptosis of Rat Hepatocytes*

  2003cited by this paper
• Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.

  2003cited by this paper
• Tauroursodeoxycholic Acid Prevents Amyloid-β Peptide-Induced Neuronal Death Via a Phosphatidylinositol 3-Kinase-Dependent Signaling Pathway

  2003cited by this paper
• Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats

  2003cited by this paper
• Modulation of Glucocorticoid Receptor Transcriptional Activation, Phosphorylation, and Growth Inhibition by p27Kip1*

  2003cited by this paper
• Inhibition of Glucocorticoid-induced Apoptosis in 697 Pre-B Lymphocytes by the Mineralocorticoid Receptor N-terminal Domain*

  2002cited by this paper
• Changes in the pattern of bile acids in the nuclei of rat liver cells during hepatocarcinogenesis.

  2002cited by this paper
• Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons

  2002cited by this paper
• Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation

  2002cited by this paper
• Neuroprotection by a Bile Acid in an Acute Stroke Model in the Rat

  2002cited by this paper
• Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types.

  2002cited by this paper
• Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease

  2002cited by this paper
• Distinct Interaction of Cortivazol with the Ligand Binding Domain Confers Glucocorticoid Receptor Specificity

  2002cited by this paper
• Tauroursodeoxycholic Acid Improves the Survival and Function of Nigral Transplants in a Rat Model of Parkinson's Disease

  2002cited by this paper
• Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-κB-dependent Transcription by Ursodeoxycholic Acid*

  2001cited by this paper
• A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.

  2001cited by this paper
• A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide.

  2001cited by this paper
• Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate.

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants.

  2001cited by this paper
• Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease.

  2001cited by this paper
• A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide

  2001cited by this paper
• Coping with Schizophrenia: Patterns in Later Adulthood

  2001cited by this paper
• Tauroursodeoxycholic Acid Partially Prevents Apoptosis Induced by 3‐Nitropropionic Acid

  2000cited by this paper
• 5'-heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcripts by early-life events.

  2000cited by this paper
• Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds.

  2000cited by this paper
• Subtle shifts in the ratio between pro‐ and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate

  2000cited by this paper
• Identification of a nuclear receptor for bile acids.

  1999cited by this paper
• Bile acids: natural ligands for an orphan nuclear receptor.

  1999cited by this paper
• Structural Determinants of Aldosterone Binding Selectivity in the Mineralocorticoid Receptor*

  1999cited by this paper
• Steroid hormone receptors: Evolution, ligands, and molecular basis of biologic function

  1999cited by this paper
• Direct Association with Thioredoxin Allows Redox Regulation of Glucocorticoid Receptor Function*

  1999cited by this paper
• Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation

  1999cited by this paper
• Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors

  1999cited by this paper
• Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.

  1999cited by this paper
• Plasticity of hippocampal corticosteroid receptors during aging in the rat

  1999cited by this paper
• A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.

  1998cited by this paper
• Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors.

  1998cited by this paper
• Inhibition by dexamethasone of transforming growth factor β1,–induced apoptosis in rat hepatoma cells: A possible association with Bcl‐xL induction

  1998cited by this paper
• Mineralocorticoid receptors regulate bcl‐2 and p53 mRNA expression in hippocampus

  1998cited by this paper
• Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei.

  1997cited by this paper
• Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro.

  1997cited by this paper
• Fluorescent bile acid derivatives: Relationship between chemical structure and hepatic and intestinal transport in the rat

  1997cited by this paper
• Steroid receptor interactions with heat shock protein and immunophilin chaperones.

  1997cited by this paper
• Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone.

  1996cited by this paper
• Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway.

  1996cited by this paper
• Glucocorticoid receptor mRNA in Alzheimer's diseased hippocampus.

  1995cited by this paper
• Hold 'em and fold 'em: chaperones and signal transduction.

  1995cited by this paper
• Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide.

  1993cited by this paper
• Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide

  1993cited by this paper
• Concerted stimulation of transcription by glucocorticoid receptors and basal transcription factors: limited transcriptional synergism suggests mediation by coactivators/adaptors.

  1991cited by this paper

• Bile Acids as Key Mediators of the Gut Microbiota–Immune Axis: Potential Biomarker and Therapeutic Perspectives

  2026cites this paper
• Effects of night lighting on avian cognitive function: Mechanisms involving neurodegeneration, metabolic dysregulation and neuroinflammatory responses

  2025cites this paper
• Increased serum total bile acid level is associated with improved prognosis of ischemic stroke.

  2025cites this paper
• Experimental laboratory models as tools for understanding modifiable dementia risk

  2024cites this paper
• Molecular mechanism and therapeutic strategy of bile acids in Alzheimer's disease from the emerging perspective of the microbiota-gut-brain axis.

  2024cites this paper
• Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3

  2024influential citation
• Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic

  2024cites this paper
• The Potential Therapeutic Approach of Ursodeoxycholic Acid as a Potent Activator of ACE‐2 on Cerebral Disorders Induced by γ‐irradiation in Rats

  2024cites this paper
• Emerging Roles of Bile Acids and TGR5 in the Central Nervous System: Molecular Functions and Therapeutic Implications

  2024cites this paper
• Roles of bile acids signaling in neuromodulation under physiological and pathological conditions

  2023cites this paper
• Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia

  2022cites this paper
• Chronic exposure to ambient traffic-related air pollution (TRAP) alters gut microbial abundance and bile acid metabolism in a transgenic rat model of Alzheimer’s disease

  2022cites this paper
• Is TGR5 a therapeutic target for the treatment of spinal cord injury?

  2022cites this paper
• Versatile Triad Alliance: Bile Acid, Taurine and Microbiota

  2022cites this paper
• The clinical and mechanistic roles of bile acids in depression, Alzheimer's disease, and stroke

  2022cites this paper
• Bile acids as regulatory molecules and potential targets in metabolic diseases.

  2021cites this paper
• From dried bear bile to molecular investigation: a systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders.

  2021cites this paper
• Ursodeoxycholic acid as a potential alternative therapeutic approach for neurodegenerative disorders: Effects on cell apoptosis, oxidative stress and inflammation in the brain

  2021influential citation
• The bile acid TUDCA and neurodegenerative disorders: An overview.

  2021cites this paper
• Bile Acid Signaling in Neurodegenerative and Neurological Disorders

  2020cites this paper
• Peripheral serum metabolomic profiles inform central cognitive impairment

  2020cites this paper
• Peripheral Serum Metabolomic Profiles Inform Antecedent Central Cognitive Impairment in Older Adults

  2019cites this paper
• Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease

  2019cites this paper
• Calbindin-D9k is a Novel Risk Gene for Neurodegenerative Disease.

  2019cites this paper
• Peroxiredoxin 4 ameliorates amyloid beta oligomer-mediated apoptosis by inhibiting ER-stress in HT-22 hippocampal neuron cells

  2019cites this paper
• Tauroursodeoxycholate—Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives

  2019influential citation
• Modulation of Cell Fate by Tauroursodeoxycholic Acid: All Paths Lead to Mitochondria

  2018cites this paper
• Free oxysterols and bile acids including conjugates - Simultaneous quantification in human plasma and cerebrospinal fluid by liquid chromatography-tandem mass spectrometry.

  2018cites this paper
• Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System

  2017cites this paper
• Neuroprotective effects of TUDCA in Parkinson’s disease: dissecting the anti-oxidant and anti-inflammatory effects of this bile acid in the mouse cerebral cortex

  2017cites this paper
• Bile Acids in Neurodegenerative Disorders

  2016cites this paper
• The Brain Metabolome of Male Rats across the Lifespan

  2016cites this paper
• Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease

  2016cites this paper
• Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury?

  2016cites this paper
• Role of a Bile Acid in Improving Survival and Function of Neural Stem Cells

  2015cites this paper
• Tauroursodeoxycholic acid prevents stress induced aggregation of proteins in vitro and promotes PERK activation in HepG2 cells.

  2015cites this paper
• Tauroursodeoxycholic Acid, a Bile Acid, Promotes Blood Vessel Repair by Recruiting Vasculogenic Progenitor Cells

  2015cites this paper
• Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice

  2014cites this paper
• Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice

  2014cites this paper
• Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice.

  2013cites this paper
• Amyloid β peptide and p63:two prime triggers of neural apoptosis and differentiation

  2013cites this paper
• Waking Action of Ursodeoxycholic Acid (UDCA) Involves Histamine and GABAA Receptor Block

  2012cites this paper
• TUDCA, a Bile Acid, Attenuates Amyloid Precursor Protein Processing and Amyloid-β Deposition in APP/PS1 Mice

  2012cites this paper
• Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson’s Disease

  2012cites this paper
• Endoplasmic Reticulum Stress and Lipid Metabolism

  2012cites this paper
• Bile in the Brain? A Role for Bile Acids in the Central Nervous System

  2012cites this paper
• c-Jun Regulates the Stability of Anti-Apoptotic ΔNp63 in Amyloid-β-Induced Apoptosis

  2012cites this paper
• Ursodeoxycholic Acid Protects Colon Cancer HCT116 Cells From Deoxycholic Acid-Induced Apoptosis by Inhibiting Apoptosome Formation

  2012cites this paper
• Tauroursodeoxycholic acid : a novel neuroprotective drug in diabetic retinopathy?

  2011cites this paper
• Ursodeoxycholic acid amides as novel glucocorticoid receptor modulators.

  2011cites this paper
• Endoplasmic Reticulum Stress and Lipid Metabolism: Mechanisms and Therapeutic Potential

  2011cites this paper
• An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders

  2010cites this paper
• APOPTOSIS SIGNALING ASSOCIATED WITH AMYLOID -INDUCED CELLULAR DYSFUNCTION AND DEGENERATION

  2010cites this paper
• Apoptosis signaling associated with amyloid β-induced cellular dysfunction and degeneration : relevance for Alzheimer’s disease

  2010influential citation
• Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases

  2010cites this paper
• Cell death targets and potential modulators in Alzheimer's disease.

  2010cites this paper
• No evidence of direct binding between ursodeoxycholic acid and the p53 DNA-binding domain.

  2010influential citation
• Tauroursodeoxycholic acid prevents E22Q Alzheimer’s Aβ toxicity in human cerebral endothelial cells

  2009cites this paper
• Bile acids: regulation of apoptosis by ursodeoxycholic acid

  2009cites this paper
• Role of nuclear steroid receptors in apoptosis.

  2009cites this paper
• Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease.

  2008cites this paper
• Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats.

  2008cites this paper
• p53, A NOVEL MOLECULAR TARGET OF URSODEOXYCHOLIC ACID IN MODULATING HEPATOCYTE APOPTOSIS

  2008cites this paper
• Function of nuclear steroid receptors in apoptosis: role of ursodeoxycholic acid

  2007cites this paper
• ROLE OF APOPTOSIS AND ITS MODULATION

  2007cites this paper
• Amyloid-b pathology is attenuated by tauroursodeoxycholic acid treatment in APP / PS 1 mice after disease onset

  year unknowncites this paper